Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment (SING-PD)

This study has been completed.
Sponsor:
Collaborator:
Michael J. Fox Foundation for Parkinson's Research
Information provided by:
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT01163331
First received: July 14, 2010
Last updated: June 20, 2011
Last verified: June 2011
  Purpose

This study will compare group singing to group speech therapy without singing. You may be eligible for this study if you have been diagnosed with PD for one year or more and you have a quiet voice or difficulty being understood.


Condition Intervention
Voice Quality and Voice Loudness Associated With Parkinson's Disease
Other: Singing Therapy

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing

Resource links provided by NLM:


Further study details as provided by Beth Israel Deaconess Medical Center:

Primary Outcome Measures:
  • Vocal Loudness, Vocal Quality [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: March 2010
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Singing Therapy Group
Singing Therapy Group
Other: Singing Therapy
Singing therapy as a way to improve voice quality

Detailed Description:

The National Parkinson Foundation Center of Excellence at Beth Israel Deaconess Medical Center is conducting a research study to test whether group singing therapy helps people with voice or speech disorders due to Parkinson's disease (PD). Communication problems, including loss of vocal loudness, affect many people with PD. While existing forms of speech therapy have been shown to be helpful, group singing may be a beneficial alternative to traditional speech therapy.

The study will involve participating in weekly treatment sessions where subjects will receive training in vocal exercises from a speech-language pathologist with expertise in PD, as well as instructions for structured home practice. Participants will be assigned to a singing or non-singing group for the 12-week treatment phase of the study. Researchers will measure subjects' vocal function and communication-related quality of life before and several times after the 12-week program. All subjects and their care partners are welcome to participate in a singing group following the study.

You may be eligible for this study if you have been diagnosed with PD for one year or more, and you have difficulty with your voice or speech such as quiet voice, or difficulty being understood.

  Eligibility

Ages Eligible for Study:   30 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Difficulty being heard or understood
  • Diagnosis of Parkinson's Disease for one year

Exclusion Criteria:

  • No other neurological conditions(i.e. stroke, cerebellar ataxia) that affect voice quality
  • No history of vocal chord hemorrhage
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01163331

Locations
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Michael J. Fox Foundation for Parkinson's Research
  More Information

No publications provided

Responsible Party: Dr. Daniel Tarsy, MD, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT01163331     History of Changes
Other Study ID Numbers: 2009-P-000338/1
Study First Received: July 14, 2010
Last Updated: June 20, 2011
Health Authority: United States:Beth Israel Deaconess Medical Center, Institutional Review Board; Commitee on Clinical Investigations

Keywords provided by Beth Israel Deaconess Medical Center:
Parkinson's Disease, voice quality, vocal strength, voice loudness

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on April 22, 2014